Nrf2 in toxic models of degenerative disorders: an approache to Parkinson's and huntington's disease

被引：0
|
作者：
Ali, S. F. [1 ]
Tobon-Velasco, J. C. [2 ,3 ]
Pedraza-Chaverri, J. [3 ]
Cuadrado, A. [4 ]
Maldonado, P. D. [2 ]
Santamaria, A. [1 ,2 ]
机构：
[1] NCTR, Div Neurotox, Neurochem Lab, Jefferson, AR USA
[2] MVS SSA, Inst Nacl Neurol & Neurocirugia, Lab Aminoacids Excitadores, Mexico City, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Dept Biol, Fac Quim, Mexico City, DF, Mexico
[4] Inst Invest Biomedades, Madrid, Spain
来源：
JOURNAL OF NEUROCHEMISTRY | 2013年 / 125卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [41] Neuroprotective effect of Ginsenoside Re against neurotoxin-induced Parkinson's disease models via induction of Nrf2
    Qiao, Juhui
    Zhao, Yuchu
    Liu, Ying
    Zhang, Siyu
    Zhao, Wenxue
    Liu, Shichao
    Liu, Meichen
    MOLECULAR MEDICINE REPORTS, 2022, 25 (06)
  • [42] The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders
    Gao, Bifeng
    Doan, An
    Hybertson, Brooks M.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2014, 6 : 19 - 34
  • [43] Nrf2 Activation Rescues Dendritic Pathology in hPSC-Derived And Primary Neuron Based Models of Parkinson's Disease
    Drolet, Jennifer
    Czaniecki, Christopher
    Ryan, Tammy
    Stykel, Morgan
    Coackley, Carla
    Ryan, Scott
    FASEB JOURNAL, 2018, 32 (01):
  • [44] Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models
    Guo, Baojian
    Zheng, Chengyou
    Cao, Jie
    Luo, Fangcheng
    Li, Haitao
    Hu, Shengquan
    Lee, Simon Mingyuan
    Yang, Xifei
    Zhang, Gaoxiao
    Zhang, Zaijun
    Sun, Yewei
    Wang, Yuqiang
    JOURNAL OF ADVANCED RESEARCH, 2024, 64 : 195 - 211
  • [45] Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease
    Peters, Owen M.
    Weiss, Alexandra
    Metterville, Jake
    Song, Lina
    Logan, Robert
    Smith, Gaynor A.
    Schwarzschild, Michael A.
    Mueller, Christian
    Brown, Robert H.
    Freeman, Marc
    NEUROBIOLOGY OF DISEASE, 2021, 155
  • [46] Verb processing in Parkinson's disease and Huntington's disease
    Peran, P.
    Goutines, E.
    Demonet, J. F.
    Rascol, O.
    Cardebat, D.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 282 - 283
  • [47] Parkinson's disease and Huntington's disease by PET and MRI
    Piccini, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 21 - 22
  • [48] Sleep Disorders in Rodent Models of Parkinson's Disease
    Medeiros, Daniel de Castro
    Aguiar, Cleiton Lopes
    Dutra Moraes, Marcio Flavio
    Fisone, Gilberto
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [49] TARGETING THE NRF2 PATHWAY IN HUNTINGTON'S DISEASE: FUMARIC ACID ESTERS AS A NEW THERAPEUTIC OPTION IN NEURODEGENERATION?
    Ellrichmann, G.
    Lee, D-H
    Reick, C.
    Arning, L.
    Petrasch-Parwez, E.
    Saft, C.
    Gold, R.
    Linker, R. A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A14 - A14
  • [50] Gene therapy for Parkinson's and Huntington's disease
    Kordower, JH
    McBride, J
    MOVEMENT DISORDERS, 2004, 19 : S8 - S8
12345